I am listening to the conference call and the future looks optimistic to say the least. AMRI is rock bottom now and it is trading at over 10% less than book value. I bet a few companies are going to try and buy AMRI considering their bright future. The stock took a wack today, but the future looks good. 9 new compounds are in 3rd clinical trials. 2 already have customers ready to buy them. Good luck to all.
>I am listening to the conference call and the >future looks optimistic to say the least. >AMRI is rock bottom now and it is trading at >over 10% less than book value. I bet a few >companies are going to try and buy AMRI >considering their bright future.
I must reply to this news.
Come on - please give better reasons - logic is going to jump down this. Michael Moore could make a movie that would do better than that.
Who wants to buy this stupid monster? Oh yes, I know who wants to buy it - Angelica Jolie! If anything you are talking here was a truth, it should really get the price moving up monday.
By the time AMRI will only have diluted the shares with further financing - expect no return to shareholders.
From AMRI Profile: CEO Dr. D'Ambra is paid 5.41M, (and exercised 1.01M) to run a company that earned 20M last year and lost 15M this year on 123M revenue. Assuming these figures are correct, Dr. D'Ambra has earned more than AMRI in the past 2 years(?) I compared this to a favorite from my portfolio: CEO paid 4M/revenue 30B/earnings 2B. Anybody holding AMRI must have a lot of faith in this CEO. I'll look no further.